Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion
Expression of IL-33 is elevated in patients with pulmonary diseases, and full-length (not proteolytically processed) IL-33 is the predominant form in the lungs in health and disease. To determine whether activation of IL-33 is needed for functional effects, activities of full-length mouse and mature...
Saved in:
Published in | The Journal of immunology (1950) Vol. 189; no. 1; pp. 403 - 410 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.07.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Expression of IL-33 is elevated in patients with pulmonary diseases, and full-length (not proteolytically processed) IL-33 is the predominant form in the lungs in health and disease. To determine whether activation of IL-33 is needed for functional effects, activities of full-length mouse and mature mouse (mm) forms of IL-33 were compared in vivo. Replication-deficient adenoviral constructs were used for gene delivery. Both isoforms caused pulmonary infiltration of lymphocytes and neutrophils, whereas mm IL-33 also caused pulmonary eosinophilia and goblet cell hyperplasia and increased expression of IL-4, IL-5, IL-13, IL-17, MCP-1, and KC. The different effects were not associated with differential release from IL-33-producing cells or by differences in subcellular distributions of IL-33 isoforms. Germline deficiency of the cell surface receptor chain ST2 abrogated the mm IL-33-induced Th2-associated effects (pulmonary eosinophilia, goblet cell hyperplasia, and increased IL-4 and IL-5), yet the lymphocytic infiltration induced by full-length mouse IL-33 or mm IL-33 was not fully abrogated by the absence of ST2. The similar effects of IL-33 isoforms were associated with comparable regulation of gene expression, notably matrix metalloproteinases 3, 10, and 13. Thus, full-length IL-33 is functionally active in vivo in an ST2-independent fashion, and its effects are partially different from those of mature IL-33. The different effects of these isoforms, particularly the pro-Th2 effects of mature IL-33, are due to differential utilization of the IL-33R chain ST2, whereas their similar effects result from regulation of gene expression. |
---|---|
AbstractList | Expression of IL-33 is elevated in patients with pulmonary diseases, and full-length (not proteolytically processed) IL-33 is the predominant form in the lungs in health and disease. To determine whether activation of IL-33 is needed for functional effects, activities of full-length mouse and mature mouse (mm) forms of IL-33 were compared in vivo. Replication-deficient adenoviral constructs were used for gene delivery. Both isoforms caused pulmonary infiltration of lymphocytes and neutrophils, whereas mmIL-33 also caused pulmonary eosinophilia and goblet cell hyperplasia and increased expression of IL-4, IL-5, IL-13, IL-17, MCP-1, and KC. The different effects were not associated with differential release from IL-33-producing cells or by differences in subcellular distributions of IL-33 isoforms. Germline deficiency of the cell surface receptor chain ST2 abrogated the mmIL-33-induced Th2-associated effects (pulmonary eosinophilia, goblet cell hyperplasia, and increased IL-4 and IL-5), yet the lymphocytic infiltration induced by full-length mouse IL-33 or mmIL-33 was not fully abrogated by the absence of ST2. The similar effects of IL-33 isoforms were associated with comparable regulation of gene expression, notably matrix metalloproteinases 3, 10, and 13. Thus, full-length IL-33 is functionally active in vivo in an ST2-independent fashion, and its effects are partially different from those of mature IL-33. The different effects of these isoforms, particularly the pro-Th2 effects of mature IL-33, are due to differential utilization of the IL-33R chain ST2, whereas their similar effects result from regulation of gene expression. Expression of IL-33 is elevated in patients with pulmonary diseases, and full-length (not proteolytically processed) IL-33 is the predominant form in the lungs in health and disease. To determine whether activation of IL-33 is needed for functional effects, activities of full-length mouse and mature mouse (mm) forms of IL-33 were compared in vivo. Replication-deficient adenoviral constructs were used for gene delivery. Both isoforms caused pulmonary infiltration of lymphocytes and neutrophils, whereas mm IL-33 also caused pulmonary eosinophilia and goblet cell hyperplasia and increased expression of IL-4, IL-5, IL-13, IL-17, MCP-1, and KC. The different effects were not associated with differential release from IL-33-producing cells or by differences in subcellular distributions of IL-33 isoforms. Germline deficiency of the cell surface receptor chain ST2 abrogated the mm IL-33-induced Th2-associated effects (pulmonary eosinophilia, goblet cell hyperplasia, and increased IL-4 and IL-5), yet the lymphocytic infiltration induced by full-length mouse IL-33 or mm IL-33 was not fully abrogated by the absence of ST2. The similar effects of IL-33 isoforms were associated with comparable regulation of gene expression, notably matrix metalloproteinases 3, 10, and 13. Thus, full-length IL-33 is functionally active in vivo in an ST2-independent fashion, and its effects are partially different from those of mature IL-33. The different effects of these isoforms, particularly the pro-Th2 effects of mature IL-33, are due to differential utilization of the IL-33R chain ST2, whereas their similar effects result from regulation of gene expression. |
Author | Todd, Nevins W Luzina, Irina G Kopach, Pavel Pickering, Edward M Kang, Phillip H Lockatell, Virginia Papadimitriou, John C McKenzie, Andrew N J Atamas, Sergei P |
Author_xml | – sequence: 1 givenname: Irina G surname: Luzina fullname: Luzina, Irina G organization: Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA – sequence: 2 givenname: Edward M surname: Pickering fullname: Pickering, Edward M – sequence: 3 givenname: Pavel surname: Kopach fullname: Kopach, Pavel – sequence: 4 givenname: Phillip H surname: Kang fullname: Kang, Phillip H – sequence: 5 givenname: Virginia surname: Lockatell fullname: Lockatell, Virginia – sequence: 6 givenname: Nevins W surname: Todd fullname: Todd, Nevins W – sequence: 7 givenname: John C surname: Papadimitriou fullname: Papadimitriou, John C – sequence: 8 givenname: Andrew N J surname: McKenzie fullname: McKenzie, Andrew N J – sequence: 9 givenname: Sergei P surname: Atamas fullname: Atamas, Sergei P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22634619$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kL1PwzAQxS1URD9gZ0IeWVzOdmInI6ooVKrEQJkjJ7FpqtgOcVKJ_x5XLSz3pLv3nnS_OZo47zRC9xSWCST506GxdnS-XVIGwNL8Cs1omgIRAsQEzeKOESqFnKJ5CAcAEMCSGzRlTPBE0HyGyvXYtqTV7mvY482WcI673ls_6IAbZ1plrRoa73A5Dtj5Ae_2DPc6dN4FHR342Bz9SZXDHztGGlfrTsfhBmxU2MfoLbo2qg367qIL9Ll-2a3eyPb9dbN63pKKy2QgCjKTlzKBipeVpFSkQua1LNMKeKlTwzMTLzXwJMtzpeo6K4VhRnCqNeMV5wv0eO6ND3yPOgyFbUKl21Y57cdQRDJUUJnmabTC2Vr1PoRem6LrG6v6n4JCcSJb_JEtLmRj5OHSPpZW1_-BP5T8F-dgeA4 |
CitedBy_id | crossref_primary_10_1093_cvr_cvy166 crossref_primary_10_1016_j_jid_2021_05_033 crossref_primary_10_3390_ijms21144985 crossref_primary_10_1586_14760584_2015_1011135 crossref_primary_10_3390_ijms232113457 crossref_primary_10_1007_s13770_021_00425_1 crossref_primary_10_1074_jbc_M113_534396 crossref_primary_10_3390_cancers13133281 crossref_primary_10_1016_j_cyto_2016_10_010 crossref_primary_10_1177_1753425919861774 crossref_primary_10_3389_fimmu_2018_02432 crossref_primary_10_1016_S2213_2600_13_70261_3 crossref_primary_10_3389_fphys_2020_567675 crossref_primary_10_1136_gutjnl_2012_303920 crossref_primary_10_1016_j_mam_2021_101000 crossref_primary_10_1074_jbc_M117_807636 crossref_primary_10_1016_j_intimp_2021_108069 crossref_primary_10_1111_ajt_17084 crossref_primary_10_1016_j_coi_2016_05_004 crossref_primary_10_1097_ICL_0000000000000158 crossref_primary_10_1007_s12079_023_00788_1 crossref_primary_10_1111_crj_13541 crossref_primary_10_1016_j_bbrep_2015_12_007 crossref_primary_10_1016_j_cyto_2022_155961 crossref_primary_10_1073_pnas_2123267119 crossref_primary_10_1371_journal_pone_0134226 crossref_primary_10_1165_rcmb_2013_0093OC crossref_primary_10_1186_s12890_017_0380_z crossref_primary_10_1189_jlb_3RU0115_012R crossref_primary_10_3389_fimmu_2015_00476 crossref_primary_10_1111_imcb_12159 crossref_primary_10_1016_j_biocel_2013_11_008 crossref_primary_10_3389_fimmu_2018_02663 crossref_primary_10_1177_1535370220915428 crossref_primary_10_1016_j_imlet_2017_11_012 crossref_primary_10_1016_j_cellin_2022_100042 crossref_primary_10_1111_imm_12755 crossref_primary_10_1111_imm_13404 crossref_primary_10_1016_j_yjmcc_2019_01_018 crossref_primary_10_1186_s12931_023_02334_4 crossref_primary_10_1016_j_bbadis_2014_06_009 crossref_primary_10_1016_j_coi_2014_03_004 crossref_primary_10_1038_cddis_2015_418 crossref_primary_10_1038_s41598_017_10894_x crossref_primary_10_1186_s12936_015_0922_x crossref_primary_10_1111_imm_12111 crossref_primary_10_3389_fimmu_2021_675169 crossref_primary_10_1038_mi_2015_59 crossref_primary_10_1002_eji_201545696 crossref_primary_10_1186_s13046_018_0839_7 crossref_primary_10_1016_j_alit_2023_07_002 crossref_primary_10_1016_j_vaccine_2015_03_086 crossref_primary_10_1002_cti2_1300 crossref_primary_10_1158_0008_5472_CAN_13_2729 crossref_primary_10_3390_jcm8101590 crossref_primary_10_1155_2014_587376 crossref_primary_10_4168_aair_2017_9_4_299 crossref_primary_10_1007_s10620_014_3463_1 crossref_primary_10_4049_jimmunol_1501820 crossref_primary_10_1038_s41590_021_01011_2 crossref_primary_10_1097_MOO_0000000000000503 crossref_primary_10_1016_j_healun_2022_09_018 crossref_primary_10_1007_s00281_016_0559_z crossref_primary_10_1016_j_chest_2021_06_058 crossref_primary_10_1016_j_ebiom_2018_07_004 crossref_primary_10_1016_j_cellimm_2020_104203 crossref_primary_10_3892_mmr_2015_4516 crossref_primary_10_1124_jpet_115_224675 crossref_primary_10_1016_j_cyto_2014_11_008 crossref_primary_10_1111_exd_12076 crossref_primary_10_1155_2016_9858374 crossref_primary_10_1038_s41420_020_0267_2 crossref_primary_10_1002_ijc_28481 crossref_primary_10_1371_journal_pone_0062144 crossref_primary_10_3390_ijms222413288 crossref_primary_10_3390_ijms21113933 crossref_primary_10_1186_ar4143 crossref_primary_10_3389_fimmu_2018_02601 crossref_primary_10_1038_nrgastro_2015_94 crossref_primary_10_1152_ajplung_00346_2015 crossref_primary_10_3389_fimmu_2018_01476 crossref_primary_10_1016_j_cyto_2019_02_015 crossref_primary_10_1007_s00430_022_00755_4 crossref_primary_10_4110_in_2018_18_e6 crossref_primary_10_1016_j_cellimm_2022_104657 crossref_primary_10_1016_j_jaci_2024_01_017 |
Cites_doi | 10.1378/chest.124.4.1206 10.1073/pnas.0712116105 10.4049/jimmunol.0802387 10.1016/j.bbrc.2009.07.018 10.1164/ajrccm.164.2.2008120 10.1164/rccm.200812-1902OC 10.1165/rcmb.2006-0033OC 10.1165/rcmb.2010-0516OC 10.1002/jcp.20452 10.1016/j.immuni.2009.05.007 10.1074/jbc.M901744200 10.1016/j.ijrobp.2009.12.043 10.1016/j.immuni.2005.09.015 10.1016/j.imlet.2010.04.005 10.1038/nri2691 10.1186/1471-2172-11-52 10.4049/jimmunol.1003080 10.1002/eji.200737547 10.4049/jimmunol.166.5.3143 10.1016/j.bbrc.2009.12.107 10.2353/ajpath.2007.061167 10.1007/s10067-011-1686-5 10.1084/jem.191.6.1069 10.1084/jem.193.7.785 10.1002/eji.201141629 10.1038/nri2692 10.1093/intimm/dxr006 10.1093/intimm/dxn060 10.1016/j.bbaexp.2005.01.012 10.1016/j.yexmp.2007.04.003 10.1111/j.1365-2567.2010.03393.x 10.1159/000327259 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5 10.1165/ajrcmb.24.5.4160 10.1111/j.1600-065X.2008.00624.x 10.1002/art.24435 10.4049/jimmunol.167.2.724 10.1073/pnas.0812690106 10.1189/jlb.0510271 10.1182/blood.V78.3.616.616 10.1073/pnas.95.12.6930 10.1002/art.21950 10.4049/jimmunol.0802449 10.1136/ard.2009.120113 10.1016/j.bbrc.2009.06.008 10.1084/jem.190.7.895 10.1073/pnas.0606854104 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 |
DOI | 10.4049/jimmunol.1200259 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 410 |
ExternalDocumentID | 10_4049_jimmunol_1200259 22634619 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Comparative Study Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Medical Research Council grantid: MC_U105178805 – fundername: NHLBI NIH HHS grantid: R21 HL106196 – fundername: CSRD VA grantid: I01 CX000107 – fundername: NHLBI NIH HHS grantid: 1R21HL106196 – fundername: NIAMS NIH HHS grantid: 1R03AR054946 – fundername: NIAMS NIH HHS grantid: R03 AR054946 – fundername: CSRD VA grantid: I01 CX000101 |
GroupedDBID | --- -~X .55 18M 1KJ 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 79B 85S AARDX ABCQX ABJNI ABOCM ABPPZ ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADNWM AENEX AFHIN AFOSN AFRAH AHWXS AIZAD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CUY CVF D0L DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 IH2 K-O KQ8 L7B NPM OK1 P0W P2P PQQKQ R.V RHF RHI RZQ SJN TR2 TWZ W8F WH7 WOQ X7M XJT XSW XTH YHG 5WD AAYXX CITATION OCZFY 7T5 H94 |
ID | FETCH-LOGICAL-c374t-a08f9b740c3bc71165679d7b5c03be5f38fc3bd034899aadd8b6f2f631ee23c33 |
ISSN | 0022-1767 |
IngestDate | Tue Dec 03 23:18:35 EST 2024 Fri Dec 06 03:10:44 EST 2024 Sat Sep 28 07:52:11 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c374t-a08f9b740c3bc71165679d7b5c03be5f38fc3bd034899aadd8b6f2f631ee23c33 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.jimmunol.org/content/jimmunol/189/1/403.full.pdf |
PMID | 22634619 |
PQID | 1551617595 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1551617595 crossref_primary_10_4049_jimmunol_1200259 pubmed_primary_22634619 |
PublicationCentury | 2000 |
PublicationDate | 2012-Jul-01 2012-07-01 20120701 |
PublicationDateYYYYMMDD | 2012-07-01 |
PublicationDate_xml | – month: 07 year: 2012 text: 2012-Jul-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2012 |
References | 20075389 - Am J Respir Crit Care Med. 2010 Jun 15;181(12):1329-35 21219317 - Immunology. 2011 Mar;132(3):385-93 1830498 - Blood. 1991 Aug 1;78(3):616-23 19439663 - Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9021-6 19596270 - Biochem Biophys Res Commun. 2009 Sep 11;387(1):218-22 10727469 - J Exp Med. 2000 Mar 20;191(6):1069-76 19801525 - J Immunol. 2009 Oct 15;183(8):5094-103 20035719 - Biochem Biophys Res Commun. 2010 Jan 15;391(3):1512-6 18250323 - Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2723-8 14555548 - Chest. 2003 Oct;124(4):1206-14 19465481 - J Biol Chem. 2009 Jul 17;284(29):19420-6 16286016 - Immunity. 2005 Nov;23(5):479-90 19404954 - Arthritis Rheum. 2009 May;60(5):1530-9 11283151 - J Exp Med. 2001 Apr 2;193(7):785-92 19995743 - Ann Rheum Dis. 2010 Jan;69 Suppl 1:i43-47 11350822 - Am J Respir Cell Mol Biol. 2001 May;24(5):537-44 17569779 - Am J Pathol. 2007 Aug;171(2):428-37 21285395 - J Leukoc Biol. 2011 May;89(5):763-70 20081871 - Nat Rev Immunol. 2010 Feb;10(2):89-102 21246230 - Clin Rheumatol. 2011 Jun;30(6):825-30 21734074 - J Immunol. 2011 Aug 15;187(4):1609-16 17853410 - Eur J Immunol. 2007 Oct;37(10):2779-86 11441076 - J Immunol. 2001 Jul 15;167(2):724-32 19508862 - Biochem Biophys Res Commun. 2009 Aug 14;386(1):181-5 15733533 - Biochim Biophys Acta. 2005 Apr 5;1728(1-2):53-64 16021625 - J Cell Physiol. 2006 Jan;206(1):221-8 18550585 - Int Immunol. 2008 Aug;20(8):1019-30 19933859 - J Immunol. 2009 Dec 15;183(12):7890-7 21646790 - Int Arch Allergy Immunol. 2011;155 Suppl 1:12-20 21887788 - Eur J Immunol. 2011 Nov;41(11):3351-60 16868995 - Arthritis Rheum. 2006 Aug;54(8):2643-55 17540368 - Exp Mol Pathol. 2007 Oct;83(2):169-76 11207266 - J Immunol. 2001 Mar 1;166(5):3143-50 21422152 - Int Immunol. 2011 May;23(5):307-15 17185418 - Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):282-7 12355452 - Eur J Immunol. 2002 Oct;32(10):2979-87 20081870 - Nat Rev Immunol. 2010 Feb;10(2):103-10 11463601 - Am J Respir Crit Care Med. 2001 Jul 15;164(2):277-81 9618516 - Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6930-5 20958987 - BMC Immunol. 2010;11:52 18830919 - Curr Opin Mol Ther. 2008 Oct;10(5):439-48 19559631 - Immunity. 2009 Jul 17;31(1):84-98 20412815 - Immunol Lett. 2010 Jul 8;131(2):159-65 10510079 - J Exp Med. 1999 Oct 4;190(7):895-902 20457355 - Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):582-90 21642589 - Am J Respir Cell Mol Biol. 2011 Dec;45(6):1125-32 18613828 - Immunol Rev. 2008 Jun;223:20-38 16601239 - Am J Respir Cell Mol Biol. 2006 Sep;35(3):298-305 Luzina (2023010205082131900_r28) 2006; 206 Townsend (2023010205082131900_r29) 2000; 191 Warner (2023010205082131900_r44) 2001; 24 Pochetuhen (2023010205082131900_r22) 2007; 171 Smithgall (2023010205082131900_r41) 2008; 20 Carriere (2023010205082131900_r5) 2007; 104 Tajima (2023010205082131900_r20) 2003; 124 Joshi (2023010205082131900_r40) 2010; 11 Verri (2023010205082131900_r42) 2008; 105 Gosselink (2023010205082131900_r46) 2010; 181 Flechsig (2023010205082131900_r47) 2010; 77 Zhiguang (2023010205082131900_r14) 2010; 131 Coyle (2023010205082131900_r37) 1999; 190 Lécart (2023010205082131900_r7) 2002; 32 Luzina (2023010205082131900_r27) 2006; 35 Ali (2023010205082131900_r10) 2010; 391 Cayrol (2023010205082131900_r12) 2009; 106 Parker (2023010205082131900_r48) 2008; 10 Luzina (2023010205082131900_r24) 2011; 132 Hayakawa (2023010205082131900_r8) 2009; 387 Lüthi (2023010205082131900_r13) 2009; 31 Schmitz (2023010205082131900_r6) 2005; 23 Luzina (2023010205082131900_r21) 2006; 54 Murphy (2023010205082131900_r4) 2010; 69 Ali (2023010205082131900_r43) 2011; 187 Ohno (2023010205082131900_r9) 2009; 183 Matsushime (2023010205082131900_r26) 1991; 78 Luzina (2023010205082131900_r25) 2011; 89 Talabot-Ayer (2023010205082131900_r11) 2009; 284 Louten (2023010205082131900_r31) 2011; 23 Liu (2023010205082131900_r36) 2009; 386 Yanaba (2023010205082131900_r18) 2011; 30 Löhning (2023010205082131900_r34) 1998; 95 Kurokawa (2023010205082131900_r16) 2011; 155 Oshikawa (2023010205082131900_r19) 2001; 164 Sims (2023010205082131900_r2) 2010; 10 Komai-Koma (2023010205082131900_r30) 2007; 37 Meisel (2023010205082131900_r35) 2001; 166 Liew (2023010205082131900_r3) 2010; 10 Yang (2023010205082131900_r39) 2011; 41 Le Goffic (2023010205082131900_r17) 2011; 45 Luzina (2023010205082131900_r23) 2009; 60 Nawijn (2023010205082131900_r32) 2001; 167 Préfontaine (2023010205082131900_r15) 2009; 183 Arend (2023010205082131900_r1) 2008; 223 Nerusu (2023010205082131900_r45) 2007; 83 Hayakawa (2023010205082131900_r33) 2005; 1728 Walzl (2023010205082131900_r38) 2001; 193 |
References_xml | – volume: 124 start-page: 1206 year: 2003 ident: 2023010205082131900_r20 article-title: The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. publication-title: Chest doi: 10.1378/chest.124.4.1206 contributor: fullname: Tajima – volume: 105 start-page: 2723 year: 2008 ident: 2023010205082131900_r42 article-title: IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0712116105 contributor: fullname: Verri – volume: 183 start-page: 5094 year: 2009 ident: 2023010205082131900_r15 article-title: Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. publication-title: J. Immunol. doi: 10.4049/jimmunol.0802387 contributor: fullname: Préfontaine – volume: 387 start-page: 218 year: 2009 ident: 2023010205082131900_r8 article-title: Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2009.07.018 contributor: fullname: Hayakawa – volume: 164 start-page: 277 year: 2001 ident: 2023010205082131900_r19 article-title: Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/ajrccm.164.2.2008120 contributor: fullname: Oshikawa – volume: 181 start-page: 1329 year: 2010 ident: 2023010205082131900_r46 article-title: Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.200812-1902OC contributor: fullname: Gosselink – volume: 35 start-page: 298 year: 2006 ident: 2023010205082131900_r27 article-title: PKCα mediates CCL18-stimulated collagen production in pulmonary fibroblasts. publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.2006-0033OC contributor: fullname: Luzina – volume: 45 start-page: 1125 year: 2011 ident: 2023010205082131900_r17 article-title: Infection with influenza virus induces IL-33 in murine lungs. publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.2010-0516OC contributor: fullname: Le Goffic – volume: 206 start-page: 221 year: 2006 ident: 2023010205082131900_r28 article-title: CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity. publication-title: J. Cell. Physiol. doi: 10.1002/jcp.20452 contributor: fullname: Luzina – volume: 31 start-page: 84 year: 2009 ident: 2023010205082131900_r13 article-title: Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. publication-title: Immunity doi: 10.1016/j.immuni.2009.05.007 contributor: fullname: Lüthi – volume: 284 start-page: 19420 year: 2009 ident: 2023010205082131900_r11 article-title: Interleukin-33 is biologically active independently of caspase-1 cleavage. publication-title: J. Biol. Chem. doi: 10.1074/jbc.M901744200 contributor: fullname: Talabot-Ayer – volume: 77 start-page: 582 year: 2010 ident: 2023010205082131900_r47 article-title: Loss of matrix metalloproteinase-13 attenuates murine radiation-induced pulmonary fibrosis. publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2009.12.043 contributor: fullname: Flechsig – volume: 23 start-page: 479 year: 2005 ident: 2023010205082131900_r6 article-title: IL-33, an interleukin-1–like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. publication-title: Immunity doi: 10.1016/j.immuni.2005.09.015 contributor: fullname: Schmitz – volume: 131 start-page: 159 year: 2010 ident: 2023010205082131900_r14 article-title: Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. publication-title: Immunol. Lett. doi: 10.1016/j.imlet.2010.04.005 contributor: fullname: Zhiguang – volume: 10 start-page: 89 year: 2010 ident: 2023010205082131900_r2 article-title: The IL-1 family: regulators of immunity. publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2691 contributor: fullname: Sims – volume: 11 start-page: 52 year: 2010 ident: 2023010205082131900_r40 article-title: Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. publication-title: BMC Immunol. doi: 10.1186/1471-2172-11-52 contributor: fullname: Joshi – volume: 187 start-page: 1609 year: 2011 ident: 2023010205082131900_r43 article-title: The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB–stimulated gene transcription. publication-title: J. Immunol. doi: 10.4049/jimmunol.1003080 contributor: fullname: Ali – volume: 37 start-page: 2779 year: 2007 ident: 2023010205082131900_r30 article-title: IL-33 is a chemoattractant for human Th2 cells. publication-title: Eur. J. Immunol. doi: 10.1002/eji.200737547 contributor: fullname: Komai-Koma – volume: 166 start-page: 3143 year: 2001 ident: 2023010205082131900_r35 article-title: Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. publication-title: J. Immunol. doi: 10.4049/jimmunol.166.5.3143 contributor: fullname: Meisel – volume: 391 start-page: 1512 year: 2010 ident: 2023010205082131900_r10 article-title: Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2009.12.107 contributor: fullname: Ali – volume: 171 start-page: 428 year: 2007 ident: 2023010205082131900_r22 article-title: Complex regulation of pulmonary inflammation and fibrosis by CCL18. publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2007.061167 contributor: fullname: Pochetuhen – volume: 30 start-page: 825 year: 2011 ident: 2023010205082131900_r18 article-title: Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. publication-title: Clin. Rheumatol. doi: 10.1007/s10067-011-1686-5 contributor: fullname: Yanaba – volume: 191 start-page: 1069 year: 2000 ident: 2023010205082131900_r29 article-title: T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. publication-title: J. Exp. Med. doi: 10.1084/jem.191.6.1069 contributor: fullname: Townsend – volume: 193 start-page: 785 year: 2001 ident: 2023010205082131900_r38 article-title: Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. publication-title: J. Exp. Med. doi: 10.1084/jem.193.7.785 contributor: fullname: Walzl – volume: 41 start-page: 3351 year: 2011 ident: 2023010205082131900_r39 article-title: IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. publication-title: Eur. J. Immunol. doi: 10.1002/eji.201141629 contributor: fullname: Yang – volume: 10 start-page: 103 year: 2010 ident: 2023010205082131900_r3 article-title: Disease-associated functions of IL-33: the new kid in the IL-1 family. publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2692 contributor: fullname: Liew – volume: 23 start-page: 307 year: 2011 ident: 2023010205082131900_r31 article-title: Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. publication-title: Int. Immunol. doi: 10.1093/intimm/dxr006 contributor: fullname: Louten – volume: 20 start-page: 1019 year: 2008 ident: 2023010205082131900_r41 article-title: IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. publication-title: Int. Immunol. doi: 10.1093/intimm/dxn060 contributor: fullname: Smithgall – volume: 1728 start-page: 53 year: 2005 ident: 2023010205082131900_r33 article-title: T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3. publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbaexp.2005.01.012 contributor: fullname: Hayakawa – volume: 83 start-page: 169 year: 2007 ident: 2023010205082131900_r45 article-title: Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. publication-title: Exp. Mol. Pathol. doi: 10.1016/j.yexmp.2007.04.003 contributor: fullname: Nerusu – volume: 132 start-page: 385 year: 2011 ident: 2023010205082131900_r24 article-title: Splice isoforms of human interleukin-4 are functionally active in mice in vivo. publication-title: Immunology doi: 10.1111/j.1365-2567.2010.03393.x contributor: fullname: Luzina – volume: 155 start-page: 12 year: 2011 ident: 2023010205082131900_r16 article-title: Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. publication-title: Int. Arch. Allergy Immunol. doi: 10.1159/000327259 contributor: fullname: Kurokawa – volume: 32 start-page: 2979 year: 2002 ident: 2023010205082131900_r7 article-title: Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. publication-title: Eur. J. Immunol. doi: 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5 contributor: fullname: Lécart – volume: 24 start-page: 537 year: 2001 ident: 2023010205082131900_r44 article-title: Role of stromelysin 1 and gelatinase B in experimental acute lung injury. publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/ajrcmb.24.5.4160 contributor: fullname: Warner – volume: 223 start-page: 20 year: 2008 ident: 2023010205082131900_r1 article-title: IL-1, IL-18, and IL-33 families of cytokines. publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00624.x contributor: fullname: Arend – volume: 60 start-page: 1530 year: 2009 ident: 2023010205082131900_r23 article-title: Regulation of pulmonary inflammation and fibrosis through expression of integrins αVβ3 and αVβ5 on pulmonary T lymphocytes. publication-title: Arthritis Rheum. doi: 10.1002/art.24435 contributor: fullname: Luzina – volume: 10 start-page: 439 year: 2008 ident: 2023010205082131900_r48 article-title: Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications. publication-title: Curr. Opin. Mol. Ther. contributor: fullname: Parker – volume: 167 start-page: 724 year: 2001 ident: 2023010205082131900_r32 article-title: Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. publication-title: J. Immunol. doi: 10.4049/jimmunol.167.2.724 contributor: fullname: Nawijn – volume: 106 start-page: 9021 year: 2009 ident: 2023010205082131900_r12 article-title: The IL-1–like cytokine IL-33 is inactivated after maturation by caspase-1. publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0812690106 contributor: fullname: Cayrol – volume: 89 start-page: 763 year: 2011 ident: 2023010205082131900_r25 article-title: Alternatively spliced variants of interleukin-4 promote inflammation differentially. publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0510271 contributor: fullname: Luzina – volume: 78 start-page: 616 year: 1991 ident: 2023010205082131900_r26 article-title: Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1. publication-title: Blood doi: 10.1182/blood.V78.3.616.616 contributor: fullname: Matsushime – volume: 95 start-page: 6930 year: 1998 ident: 2023010205082131900_r34 article-title: T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.95.12.6930 contributor: fullname: Löhning – volume: 54 start-page: 2643 year: 2006 ident: 2023010205082131900_r21 article-title: Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. publication-title: Arthritis Rheum. doi: 10.1002/art.21950 contributor: fullname: Luzina – volume: 183 start-page: 7890 year: 2009 ident: 2023010205082131900_r9 article-title: Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. publication-title: J. Immunol. doi: 10.4049/jimmunol.0802449 contributor: fullname: Ohno – volume: 69 start-page: i43 year: 2010 ident: 2023010205082131900_r4 article-title: Role of interleukin 33 in human immunopathology. publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2009.120113 contributor: fullname: Murphy – volume: 386 start-page: 181 year: 2009 ident: 2023010205082131900_r36 article-title: Anti–IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2009.06.008 contributor: fullname: Liu – volume: 190 start-page: 895 year: 1999 ident: 2023010205082131900_r37 article-title: Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. publication-title: J. Exp. Med. doi: 10.1084/jem.190.7.895 contributor: fullname: Coyle – volume: 104 start-page: 282 year: 2007 ident: 2023010205082131900_r5 article-title: IL-33, the IL-1–like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0606854104 contributor: fullname: Carriere |
SSID | ssj0006024 |
Score | 2.4307013 |
Snippet | Expression of IL-33 is elevated in patients with pulmonary diseases, and full-length (not proteolytically processed) IL-33 is the predominant form in the lungs... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 403 |
SubjectTerms | Animals Carcinoma, Non-Small-Cell Lung - immunology Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - pathology Cell Line, Tumor Female Gene Expression Regulation - genetics Gene Expression Regulation - immunology HEK293 Cells Humans Inflammation Mediators - administration & dosage Inflammation Mediators - adverse effects Inflammation Mediators - physiology Interleukin-1 Receptor-Like 1 Protein Interleukin-33 Interleukins - adverse effects Interleukins - biosynthesis Interleukins - physiology Lung Neoplasms - immunology Lung Neoplasms - metabolism Lung Neoplasms - pathology Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Protein Biosynthesis - immunology Pulmonary Fibrosis - immunology Pulmonary Fibrosis - metabolism Pulmonary Fibrosis - pathology Receptors, Cell Surface - biosynthesis Receptors, Cell Surface - genetics Receptors, Cell Surface - physiology Receptors, Interleukin - deficiency Receptors, Interleukin - genetics Receptors, Interleukin - physiology Stem Cells - immunology Stem Cells - metabolism Stem Cells - pathology Th2 Cells - immunology Th2 Cells - metabolism Th2 Cells - pathology |
Title | Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22634619 https://search.proquest.com/docview/1551617595 |
Volume | 189 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBONWbjISPKDIWxo7Sf2IuGilg6dO2ltkJ7YWJNKppJWY-PGcYztpujEJeEmiuErU8305Psc-F0JeG6WzsrIpm-RaMqFVyqbGwOduNXa0TqpYuWqfX7OjE_H5ND0djX4Ns0tafVBe_DGv5H9QhXuAK2bJ_gOy_UPhBlwDvnAEhOH4Vxij_8iwFUp7Fs2OGecYbgWy90FWgLXPS4z0uo2aZRstzpJo5YNiXa2QTb1Z4hm_8UXC6r4lbhtZbLIUIPu2ZdTAfq0xs8RXcHrj9sniwarC8fqi9tlmsxVcDDp41RjHERqp-I7R2wXZOXrwIWBxY_rYj3lY0w47FyGfIixVTLZhrTDTBPWagrOaxdmu_pVXiOa1qXDlD65oeQFeDWr58D8PJhho4uuKD0A__-5QB_OSiyyo5d3K2t3QDXITyyhi54UPs3k_j2dgvviNbXzh4eXXYRnp8IBdm-YaR8UZLIt75G5Air7ztLlPRqbZJ7d879Gf--T2lxBV8YDoAY-o4xHteESHPKLAIwo8osAj2vEIfkGRR3hWDb3EIxp49JCcfPq4eH_EQu8NVvJctEzFUyt1LuKS6zJ3NZpyWeU6LWOuTWr51MJIFXMBDruCSXKqM5vYjE-MSXjJ-SOy1ywb84RQcMilroSw3KRCciErkSkJc0dsVWykHJO3nfSKc19ipQDXFIVedEIvgtDH5FUn3gL0IG5uqcYs1z8Kt-MLtrBMx-Sxl3v_tA6np9eOPCN3toR9Tvba1dq8AGuz1S8dKX4Dvjh_Gg |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Full-length+IL-33+promotes+inflammation+but+not+Th2+response+in+vivo+in+an+ST2-independent+fashion&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Luzina%2C+Irina+G&rft.au=Pickering%2C+Edward+M&rft.au=Kopach%2C+Pavel&rft.au=Kang%2C+Phillip+H&rft.date=2012-07-01&rft.eissn=1550-6606&rft.volume=189&rft.issue=1&rft.spage=403&rft_id=info:doi/10.4049%2Fjimmunol.1200259&rft_id=info%3Apmid%2F22634619&rft.externalDocID=22634619 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |